Medico Intercontinental Ltd

AI
Medico Intercon. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Medico Intercontinental Ltd

₹ 25.0 5.09%
05 Oct 3:23 p.m.
medicointercontinental.com BSE: 539938
About

Incorporated in 1914, Medico Intercontinental
Ltd is engaged in trading of Pharmaceutical products[1]

Key Points

Business Overview:[1][2]
MIL (Formerly M/S. Intercontinental Leasing
& Finance Company Limited) was in the textile business. Currently, it trades pharmaceutical products related to Gastro, Uro, Nutrition, Cosmetology, Health Devices, Hospital,
etc.

Website BSE
  • Market Cap ₹ 25.0 Cr.
  • Current Price ₹ 25.0
  • High / Low ₹ 43.0 / 20.6
  • Stock P/E
  • Book Value ₹ 46.9
  • Dividend Yield 0.00 %
  • ROCE -1.98 %
  • ROE -6.96 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.55 times its book value
  • Promoter holding has increased by 1.36% over last quarter.
  • Company's working capital requirements have reduced from 121 days to 76.2 days

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 3.81% over past five years.
  • Company has a low return on equity of 4.06% over last 3 years.
  • Contingent liabilities of Rs.33.8 Cr.
  • Earnings include an other income of Rs.1.13 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Services Services Commercial Services & Supplies Trading & Distributors

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
24.28 17.12 14.25 15.70 19.28 36.45 18.43 21.16 21.35 20.40 19.85 22.49 20.71
22.80 15.81 12.76 14.15 17.64 33.74 16.52 19.22 20.67 21.28 18.26 20.88 21.40
Operating Profit 1.48 1.31 1.49 1.55 1.64 2.71 1.91 1.94 0.68 -0.88 1.59 1.61 -0.69
OPM % 6.10% 7.65% 10.46% 9.87% 8.51% 7.43% 10.36% 9.17% 3.19% -4.31% 8.01% 7.16% -3.33%
0.08 0.08 0.09 0.14 0.11 0.10 0.13 0.11 0.29 0.55 0.34 0.11 0.13
Interest 0.11 0.09 0.13 0.16 0.18 0.28 0.24 0.30 2.36 2.06 1.90 1.85 1.91
Depreciation 0.07 0.07 0.07 0.08 0.08 0.20 0.23 0.28 0.62 1.95 1.43 1.43 1.21
Profit before tax 1.38 1.23 1.38 1.45 1.49 2.33 1.57 1.47 -2.01 -4.34 -1.40 -1.56 -3.68
Tax % 26.09% 29.27% 26.09% 28.28% 27.52% 29.61% 27.39% 22.45% 23.88% 4.61% 20.00% 51.28% 10.33%
1.02 0.87 1.02 1.04 1.08 1.63 1.17 1.17 -2.49 -4.51 -1.66 -2.33 -4.05
EPS in Rs 1.02 0.87 1.02 1.04 1.08 1.63 1.17 1.17 -0.68 -1.65 -0.22 -0.65 -1.45
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
0 10 82 70 74 76 71 95 84 83
0 9 78 65 69 71 66 87 81 82
Operating Profit -0 1 4 5 5 5 6 8 3 2
OPM % 7% 5% 7% 7% 7% 8% 9% 3.6% 1.9%
0 0 0 0 0 1 0 0 1 1
Interest 0 0 1 1 1 1 0 1 8 8
Depreciation 0 0 0 0 0 0 0 1 5 6
Profit before tax 0 1 3 4 4 5 5 7 -9 -11
Tax % 40% 27% 26% 27% 27% 27% 27% 27% 19%
0 1 2 3 3 4 4 5 -11 -13
EPS in Rs 0.09 2.28 7.26 7.94 9.54 3.61 3.95 5.06 -3.20 -3.97
Dividend Payout % 0% 0% 0% 0% 0% 3% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 4%
3 Years: 3%
TTM: -14%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -221%
Stock Price CAGR
10 Years: %
5 Years: -11%
3 Years: -34%
1 Year: -37%
Return on Equity
10 Years: %
5 Years: 7%
3 Years: 4%
Last Year: -7%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 3 3 3 3 3 10 10 10 10
Reserves 0 1 3 6 9 31 35 40 37
0 0 14 9 9 5 5 17 67
1 5 16 12 11 13 6 10 3
Total Liabilities 4 9 36 31 32 59 56 77 117
0 0 2 2 2 3 4 9 51
CWIP 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 3 2
4 9 34 28 30 56 53 65 64
Total Assets 4 9 36 31 32 59 56 77 117

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 1 -14 6 4 -10 6 -6 17
0 0 0 -1 -1 -5 -9 -5 2
0 0 13 -5 -1 20 -0 10 -16
Net Cash Flow 0 1 -0 -0 1 5 -3 -1 4
Free Cash Flow 0 1 -14 5 4 -11 4 -8 19
CFO/OP -6% 171% -200% 138% 100% -167% 118% -55% 629%

Ratios

Consolidated / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 237 101 94 84 157 119 124 119
Inventory Days 0 26 46 58 47 52 69 42 87
Days Payable 201 74 67 50 67 30 36 82
Cash Conversion Cycle 62 74 85 81 143 158 130 124
Working Capital Days 78 74 68 66 132 134 154 76
ROCE % 28% 36% 25% 25% 17% 12% 13% -2%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of permanent employees on rolls (standalone)
employees ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Number of wholly owned subsidiaries
subsidiaries

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
54.78% 55.08% 55.08% 55.08% 55.08% 55.17% 55.17% 55.17% 55.17% 57.15% 57.15% 58.51%
45.23% 44.93% 44.92% 44.93% 44.94% 44.83% 44.82% 44.83% 44.84% 42.86% 42.86% 41.48%
No. of Shareholders 1,1341,1193,4993,4653,5773,7593,7313,6963,6253,5753,4993,489

Documents

Announcements

Annual reports